AdnaGen AG

OncoVista (OVIT.PK) Reports 287% Increase in 2Q Revenues Due to Subsidiary's Proprietary Branded Products.
Business Wire; 11/5/2009; 690 words; ...proprietary products of our subsidiary, AdnaGen AG, are presently sold in ten countries...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...

Lab21 Ltd to Provide AdnaGen's CE-Marked System for the Detection and Analysis of Circulating Tumor Cells CTCs in the United Kingdom and Ireland.(Company overview)
Cancer Weekly; 8/25/2009; 1642 words; Lab21 Ltd and AdnaGen AG announced that they have entered into...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...biomarkers using RT-PCR. The proprietary AdnaGen approach has the clear advantage that...

Lab21 to Supply AdnaGen's CE-Marked System for the Detection and Analysis of CTCs in the UK and Ireland.
Health & Beauty Close-Up; 8/12/2009; 1097 words; Lab21 and AdnaGen AG announced that they have entered into...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...biomarkers using RT-PCR. The proprietary AdnaGen approach has the clear advantage that...

Lab21 Ltd to Provide AdnaGen's CE-Marked System for the Detection and Analysis of Circulating Tumor Cells (CTCs) in the United Kingdom and Ireland.
Business Wire; 8/10/2009; 1539 words; ...ANTONIO, Texas -- Lab21 Ltd and AdnaGen AG announced today that they have entered...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...using RT-PCR. The proprietary AdnaGen approach has the clear advantage...

OncoVista Innovative Therapies, Inc. Announces the Initiation of Clinical Development of AdnaGen's Breast Cancer Circulating Tumor Cells CTCs Diagnostic Technology in Women with High-Risk Locally Advanced Breast Cancer.(Clinical report)
Cancer Weekly; 8/4/2009; 758 words; ...Therapies, Inc. ("OncoVista") (OTC BB: OVIT.OB) and AdnaGen Ag announced that The University of Texas M. D. Anderson Cancer Center will collaborate on clinical studies of AdnaGen's molecular based CTC technology in Women with High...